OS Therapies Incorporated (NYSE:OSTX) IPO will take place July, 31 on the NYSE exchange under the ticker OSTX.

The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on January 27, 2025.

See also: Benzinga IPO Calendar

About OS Therapies Incorporated

OS Therapies Incorporated is a clinical stage biopharmaceutical company. The Company focuses on the identification, development, and commercialization of treatments for osteosarcoma (OS) and other solid tumors.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.